MyLife Diabetes Care, CamDiab and Dexcom today announced the integration of the G7 continuous glucose monitor (CGM) into the MyLoop system. MyLoop (previously MyLife Loop), an automated insulin delivery (AID) system, is powered by the CamAPS FX app. The system already integrated with the previous-generation Dexcom G6, as well as Abbott’s FreeStyle Libre 3 Plus. […]
CamDiab
The biggest diabetes tech news out of ATTD 2026
Diabetes technology innovators gathered in Barcelona last week for the 19th annual Advanced Technologies and Treatments for Diabetes Conference (ATTD 2026). At ATTD 2026, a range of companies shared the latest updates, including product launches, new clinical data, enhancements to existing offerings and more. Topics included automated insulin delivery, continuous glucose monitors (CGMs), and breakthroughs […]
CamDiab introduces fully closed-loop automated insulin delivery tech
CamDiab announced today that it is introducing CamAPS Liberty, a fully closed-loop feature for its CamAPS FX app. The integration of Liberty — which the company labeled the world’s first fully closed-loop feature — supports users with type 1 diabetes when daily demands prove challenging. It pauses the need to count carbohydrates or deliver meal […]
CamDiab earns CE mark for fully closed-loop insulin delivery algorithm
CamDiab announced that it received European approval for its fully closed-loop automated insulin delivery algorithm. The algorithm allows users to manage their type 1 diabetes without needing to count carbohydrates or providing pre-meal insulin. Cambridge, UK-based CamDiab said it marks the world’s first commercially available automated insulin delivery algorithm that enables people with type 1 […]
Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
Ypsomed and CamDiab announced today that they agreed to integrate their mylife Loop automated insulin delivery system with a future Abbott (NYSE:ABT) sensor. The companies plan to pair their pump system with the Abbott dual glucose-ketone sensor, currently under development. Ypsomed and CamDiab join three other companies set to pair their pumps with the sensor after Abbott recently […]
Ypsomed, CamDiab continue global insulin pump iPhone software rollout
Ypsomed and CamDiab announced that they continued the launch of the iOS version of their automated insulin delivery app in Europe. The two companies in March began the launch of the mylife CamAPS FX app for automated insulin delivery on iOS platforms. In combination with the mylife YpsoPump, the offering enables people with type 1 diabetes to […]
The biggest diabetes tech news out of ATTD 2025
Last week, Amsterdam played host to this year’s edition of the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD). For the 18th edition of this event, some of the biggest names in diabetes technology put their latest innovations on display. Updates for insulin delivery and glucose monitoring technologies dominated the headlines as many […]
Ypsomed, CamDiab launch iOS app for automated insulin delivery system
Ypsomed and CamDiab today announced the launch of the mylife CamAPS FX app for automated insulin delivery on iOS platforms. The app comprises part of the mylife Loop automated insulin delivery system. The iOS launch allows people with type 1 diabetes to easily and discreetly manage their pump on iPhones. Ypsomed and CamDiab plan to […]
Ypsomed reports positive outcomes with automated insulin delivery for maternal health
Ypsomed reports positive outcomes from a large, randomized trial of its closed-loop insulin delivery technology during type 1 diabetes pregnancy. The Switzerland-based company’s AiDAPT study demonstrated that hybrid closed-loop therapy significantly improves maternal glycemic control. Pregnant women with type 1 diabetes used the automated insulin delivery system based on the CamDiab CamAPS FX algorithm in […]
FDA approves hybrid closed-loop insulin delivery app from CamDiab
CamDiab announced today that the FDA granted authorization for its CamAPS FX advanced adaptive closed-loop artificial pancreas app. CamAPS FX, an Android app, received approval as an interoperable automated glycemic controller device (iAGC). It helps to manage glucose levels in people with type 1 diabetes, aged two and older, including during pregnancy. The app allows […]
